| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 08/03/2011 | CN102138983A Traditional Chinese medicine for treating hepatocirrhosis |
| 08/03/2011 | CN102138980A Medicament for treating hydrophobia and postpartum tetanus and preparation method thereof |
| 08/03/2011 | CN102138959A Quality control method of collateral-dredging lactogenesis syrup |
| 08/03/2011 | CN102138948A Medicament for treating hyperlipidemia and coronary sclerosis and preparation method thereof |
| 08/03/2011 | CN102138947A Propolis Chinese medicinal composition |
| 08/03/2011 | CN102138943A Chinese medicinal preparation for treating anemia |
| 08/03/2011 | CN102138942A Composite probiotics for prevention and adjuvant therapy of cancers and preparation method thereof |
| 08/03/2011 | CN102138941A Precursor liposome of propolis flavone and preparation method thereof |
| 08/03/2011 | CN102138940A Preparation method of termitarium capsule |
| 08/03/2011 | CN102138939A Preparation method of asterias amurensis polysaccharide extractive and medical applications thereof |
| 08/03/2011 | CN102138938A Composition for preparing products for improving hyperuricemia |
| 08/03/2011 | CN102138937A Method for processing starfishes |
| 08/03/2011 | CN102138936A Yellow dog penis extractive with resistance to ovarian function progeria as well as preparation method and applications thereof |
| 08/03/2011 | CN102138935A Melanterite-containing medicinal composition and preparation method thereof |
| 08/03/2011 | CN102138934A Emulsifiable paste for treating scabies |
| 08/03/2011 | CN102138886A Preparation for socks capable of eliminating foot smell and preventing dermatophytosis |
| 08/03/2011 | CN101890110B White tiger sesame oil scalding ointment and preparation method thereof |
| 08/03/2011 | CN101804159B Traditional Chinese medicine preparation for treating aplastic anemia |
| 08/03/2011 | CN101797362B Traditional Chinese medicine composite and preparation method thereof for treating uterine myoma of qi stagnation and blood stasis type |
| 08/03/2011 | CN101791378B Traditional Chinese medicine preparation for wound hemostasis, anti-inflammatory and tissue regeneration |
| 08/03/2011 | CN101766706B Medicinal combination containing borneol and musk |
| 08/03/2011 | CN101716214B Medical composition containing dandelion extract as well as novel application and preparation method thereof |
| 08/03/2011 | CN101683468B Medicament for treating burns and scalds and preparation method thereof |
| 08/03/2011 | CN101670056B Medicament for treating malignant tumor |
| 08/03/2011 | CN101664476B Medicinal pillow |
| 08/03/2011 | CN101658583B Traditional Chinese medicine for treating cold-dampness type skin ulcer and preparation method thereof |
| 08/03/2011 | CN101642521B Medicine for treating cerebral apoplexy hemiplegy sequela |
| 08/03/2011 | CN101628106B Traditional Chinese medicine bag for treating gynecopathy and treating equipment manufactured by same |
| 08/03/2011 | CN101628012B Medicine composition with function of regulating immunity and preparation method thereof |
| 08/03/2011 | CN101461850B Application of Chinese medicinal composition in preparing medicament for treating acne |
| 08/03/2011 | CN101411742B Capsule for freeing collateral vessels containing astragalus and leech |
| 08/03/2011 | CN101307346B Method for extracting brain strengthening bioactive peptide from brain tissue of farming animals |
| 08/03/2011 | CN101274033B Medicament composite for diabetes mellitus and preparation method thereof |
| 08/03/2011 | CN101095836B Decoction medicine for treating chronic bronchitis and method for preparing the same |
| 08/03/2011 | CN101095834B Decoction medicine for treating aypnia fantod type chronic bronchitis |
| 08/02/2011 | US7989203 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells |
| 08/02/2011 | US7989001 Method of separating tumor cells with and without lymphotropic metastatic potential in a human carcinoma |
| 08/02/2011 | US7988963 Use of allogeneic cell lines to load antigen presenting cells to elicit or eliminate immune responses |
| 08/02/2011 | US7988962 Use of polysulphated alginate in cellular matrices |
| 08/02/2011 | US7988961 Transgenic gut commensal microorganism for use as bioreactor for preparation and transfer of probiotics to eukaryotic host |
| 08/02/2011 | US7988960 Probiotics in primary prevention of atopic diseases |
| 08/02/2011 | US7988959 Method of treatment using organotypically cultured skin tissue comprising niks cells that express exogenous HIF-1a |
| 08/02/2011 | US7988951 Method for inducing selectively suppressed immune response to transplanted tissue or cells |
| 08/02/2011 | CA2650546C Use of selected lactic acid bacteria for reducing infantile colic |
| 08/02/2011 | CA2458325C Nutritional composition for controlling blood sugar level |
| 08/02/2011 | CA2442682C Monocyte-specific particulate delivery vehicle |
| 08/02/2011 | CA2412012C Resorbable extracellular matrix containing collagen i and collagen ii for reconstruction of cartilage |
| 08/02/2011 | CA2370187C Treatment of neoplasms with viruses |
| 08/02/2011 | CA2370103C Method and means for producing high titer, safe, recombinant lentivirus vectors |
| 08/02/2011 | CA2328418C Use of lipopeptides or lipoproteins for wound treatment |
| 07/28/2011 | WO2011090926A1 Nutritional formulas containing synbiotics |
| 07/28/2011 | WO2011090404A1 Composition for preparing iso-osmotic therapeutic-prophylactic baths and body wraps |
| 07/28/2011 | WO2011068438A3 Agent for the treatment and prevention of diseases of the male urogenital system |
| 07/28/2011 | WO2011060136A3 Platelet solution for use in joint surgery |
| 07/28/2011 | WO2011002239A9 Microvesicles derived from nucleated, mammalian cells and use thereof |
| 07/28/2011 | WO2010111599A3 Compositions and methods for treatment of renal disease |
| 07/28/2011 | WO2010088544A8 Methods to treat cancer |
| 07/28/2011 | US20110184381 Repair of defects or lesions in cartilage and bone using a chondro-regulative matrix |
| 07/28/2011 | US20110184153 Modified gherlin peptides |
| 07/28/2011 | US20110183934 Methods and compositions to improve germ cell and embryo survival and function |
| 07/28/2011 | US20110183021 Compositions Containing Purine Nucleosides and Manganese and Their Uses |
| 07/28/2011 | US20110183001 Compositions and methods for implantation of adipose tissue and adipose tissue products |
| 07/28/2011 | US20110183000 Artificial bone material having controlled calcium ion elution |
| 07/28/2011 | US20110182995 Medical and dental biomaterial and method of use for the same |
| 07/28/2011 | US20110182983 Human immortalised neural precursor cell line |
| 07/28/2011 | US20110182979 In-Vivo Non-Viral Gene Delivery of Human Vascular Endothelial Growth Factor Following Islet Transplantation |
| 07/28/2011 | US20110182978 Activated nitric oxide donors and methods of making and using thereof |
| 07/28/2011 | US20110182968 Interpenetrating polymer network hydrogel corneal prosthesis |
| 07/28/2011 | US20110182963 Osteoimplant and methods for making |
| 07/28/2011 | US20110182957 Cellulosics for tissue replacement |
| 07/28/2011 | US20110182950 Combination of blood and of biphasic calcium phosphate ceramic particles |
| 07/28/2011 | US20110182948 Method for treating disease characterized by plaque |
| 07/28/2011 | US20110182945 Semi-allogenic anti-tumour vaccine with hla haplo-identical antigen-presenting cells |
| 07/28/2011 | US20110182943 Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments |
| 07/28/2011 | US20110182870 Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses |
| 07/28/2011 | US20110182869 Treatment of gut motility disorders |
| 07/28/2011 | US20110182867 Modulation of bcl11a for treatment of hemoglobinopathies |
| 07/28/2011 | US20110182866 Isolation of stem cell precursors and expansion in non-adherent conditions |
| 07/28/2011 | US20110182865 Method for Prophylaxis and Treatment of Equine Herpesvirus Type 1 Infections |
| 07/28/2011 | US20110182864 Compositions containing inclusion complexes |
| 07/28/2011 | US20110182863 Anti-bacteria compositions |
| 07/28/2011 | US20110182861 Cosmetic use of microorganisms for the treatment of oily skin |
| 07/28/2011 | US20110182859 Compositions and methods for therapeutic delivery with microorganisms |
| 07/28/2011 | US20110182853 Platelet derived growth factor (pdgf)-derived neurospheres define a novel class of progenitor cells |
| 07/28/2011 | US20110182847 Use of tlr agonists and/or type 1 interferons to alleviate toxicity of tnf-r agonist therapeutic regimens |
| 07/28/2011 | US20110182813 Amphiphilic copolymers and compositions containing such polymers |
| 07/27/2011 | EP2348118A1 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) |
| 07/27/2011 | EP2348104A1 Multipotent adult stem cells and methods for isolation |
| 07/27/2011 | EP2348103A2 Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
| 07/27/2011 | EP2348102A1 Lactobacillus paracasei strain PC201, and compositions and uses thereof |
| 07/27/2011 | EP2347793A1 Method for regenerating hair follicles by suppressing a gene with hair follicle formation-inhibiting ability or by activating a gene with hair follicle formation - inducing ability |
| 07/27/2011 | EP2347763A1 An implantable neuroendoprosthesis system, a method for preparing same and a procedure for performing of a reconstructive neurosurgical operation |
| 07/27/2011 | EP2346882A1 Derivatives of 1-amino-2-cyclobutylethylboronic acid |
| 07/27/2011 | EP2346516A2 Antimicrobial composition from copepods |
| 07/27/2011 | EP2346515A1 Spinal cord injury, inflammation, and immune-disease: local controlled release of therapeutic agents |
| 07/27/2011 | EP2346514A1 Medium derived from stem cells as a pharmaceutical composition |
| 07/27/2011 | EP2346512A1 Composition for prevention and treatment of allergic and/or inflammatory diseases |
| 07/27/2011 | EP2346503A2 Kv1.3 channel blocking substances for the treatment of diseases associated with intimal hyperplasia |
| 07/27/2011 | EP2346358A1 Extract from conditioned medium cultured by regenerative cells |
| 07/27/2011 | EP2346351A2 Compositions exhibiting delayed transit through the gastrointestinal tract |